Skip to main content
. Author manuscript; available in PMC: 2023 Jun 29.
Published in final edited form as: J Perinatol. 2020 Jul 15;40(11):1671–1678. doi: 10.1038/s41372-020-0728-8

Table 1.

Prenatal and neonatal data prior to NEC

90
Prenatal information
 
Chorioamnionitis, n (%) 5 (7%)
Antenatal steroids, n (%) 44 (49%)
Maternal Indomethacin, n (%) 2 (2%)
Maternal magnesium sulphate administration, n (%) 24 (27%)
Infant Demographics
Birth weight (grams; mean ± SEM) 1008±48
Gestational age (weeks; mean ± SEM) 27.9±0.7
Small for gestational age, n (%) 14 (16%)
Male gender, n (%) 56 (62%)
Ethnicity  
 African American 79 (88%)
 Caucasian 10 (11%)
 Latino 1 (1%)
Cesarean section delivery 48 (54%)
Outborn 45 (53%)
Infant medical information prior to NEC
5 minute Apgar score 0–5, n (%) 16/90 (18%) 
Starting of enteral feedings (days, mean ± SEM) 2±0.49
Enteral feedings  
 Mother’s own/donor milk, n (%) 35 (38.4%)
 Infant formula, n (%) 55 (61.5%)
Patent Ductus Arteriosus, n (%) 42 (47%)
Patent ductus arteriosus, indomethacin treated, n (%) 16 (19%)
Patent ductus arteriosus, surgically ligated, n (%) 2 (2.2%)